![Loading Events](https://abliva.com/wp-content/plugins/the-events-calendar/src/resources/images/tribe-loading.gif)
- This event has passed.
Mitochondrial Medicine – Therapeutic Development
21 November, 2022 - 23 November, 2022
![](https://abliva.com/wp-content/uploads/2020/10/Magnus_whiteboard.jpg)
In late November, Abliva will attend the annual scientific conference Mitochondrial Medicine – Therapeutic Development in Hinxton, UK.
Abliva’s Chief Medical Officer, Magnus Hansson, will present a poster on one of the important preparatory studies for the upcoming, potentially registrational, Phase 2 study, FALCON, with KL1333 in patients with mitochondrial diseases.